Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David W. Beier | M | 75 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 16 years |
| Seth Tasker | M | 45 | 16 years | |
| Anthony Evnin | M | 83 | 18 years | |
| Norman Selby | M | 71 | 12 years | |
| Richard Gaynor | M | 74 | 4 years | |
| Richard J. Cohen | M | 73 |
Massachusetts Institute of Technology
| 45 years |
| Fady Malik | M | 60 |
The University of California, San Francisco
| 24 years |
| Jennifer Roberts | F | - | 7 years | |
| Kristine Yaffe | M | 61 |
The University of California, San Francisco
| 17 years |
| Matthew Jacobson | M | - |
The University of California, San Francisco
| 22 years |
| Donald R. Sadoway | M | - |
Massachusetts Institute of Technology
| 46 years |
| David A. Kessler | M | 72 |
The University of California, San Francisco
| 21 years |
| Mark Smith | M | 72 |
The University of California, San Francisco
| 30 years |
| Kristen Hege | M | 60 |
The University of California, San Francisco
| 28 years |
| John D. Joannopoulos | M | - |
Massachusetts Institute of Technology
| 46 years |
| Pamela Palmer | M | 61 |
The University of California, San Francisco
| 28 years |
| Scott Gilbertson | M | - |
TPG Growth LLC
 TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | 17 years |
| Alexander M. Klibanov | M | 74 |
Massachusetts Institute of Technology
| 45 years |
| Dimitri Antoniadis | M | 77 |
Massachusetts Institute of Technology
| 46 years |
| Mindy Goldman | F | - |
The University of California, San Francisco
| 31 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lawrence Bloch | M | 58 | 11 years | |
| Gerald Quirk | M | 56 | 6 years | |
| Christopher M. Lindblom | M | 52 | 8 years | |
| Harry Atwater | M | - |
Massachusetts Institute of Technology
| 10 years |
| On-kwok Li | M | 69 |
Massachusetts Institute of Technology
| 8 years |
| Franklin H. Moss | M | 75 |
Massachusetts Institute of Technology
| 16 years |
| Mark A. Clements | M | - |
Massachusetts Institute of Technology
| 3 years |
| Greg L. Zacharias | M | - |
Massachusetts Institute of Technology
| 3 years |
| John P. Walker | M | 75 |
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA.
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | 10 years |
| Adnan Akant | M | - |
Massachusetts Institute of Technology
| 5 years |
| Peter Zieve | M | 70 |
Massachusetts Institute of Technology
| 8 years |
| Thomas Lynch | M | 63 | 5 years | |
| Jeffrey Berkowitz | M | 58 | 6 years | |
| J. Wargo | M | 69 |
Massachusetts Institute of Technology
| 6 years |
| Dan Krebs | M | - |
TPG Growth LLC
TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | - |
| Gwen A. Fyfe | M | 72 | 4 years | |
| Patrick Lee | M | 67 | 7 years | |
| José Baselga | M | 65 | 3 years | |
| John M. Whiting | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 20 years |
| Martin Babler | M | 59 | 6 years | |
| Steven C. Webster | M | 67 |
Massachusetts Institute of Technology
| 5 years |
| Stefano Bertozzi | M | - |
The University of California, San Francisco
Massachusetts Institute of Technology
| 7 years |
| Jaren Madden | F | - | 7 years | |
| Steve Brown | M | - |
Massachusetts Institute of Technology
| 5 years |
| Michael Paluszek | M | - |
Massachusetts Institute of Technology
| 6 years |
| Mark Gus Alexandridis | M | 66 |
Massachusetts Institute of Technology
| 6 years |
| Tom A. Stefanick | M | - |
Massachusetts Institute of Technology
| 5 years |
| Jerry Cacia | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 28 years |
| David Roth | M | 61 |
Massachusetts Institute of Technology
| 7 years |
| Ruben Ojeda | M | - |
Massachusetts Institute of Technology
| 6 years |
| Kyu-Ha Cung | M | 72 |
Massachusetts Institute of Technology
| 7 years |
| Samuel Agresta | M | 51 | 5 years | |
| Joseph Pearlberg | M | 60 |
The University of California, San Francisco
| 8 years |
| Erik Lium | M | 56 |
The University of California, San Francisco
| 8 years |
| S. Connelly | M | - |
The University of California, San Francisco
| 8 years |
| Montgomery Alger | M | 67 |
Massachusetts Institute of Technology
| 5 years |
| Craig Dudenhoeffer | M | - |
The University of California, San Francisco
| 16 years |
| Bob Frankston | M | - |
Massachusetts Institute of Technology
| 5 years |
| Ian Smith | M | 58 | 11 years | |
| John A. DeTore | M | - |
Massachusetts Institute of Technology
| 7 years |
| Louis C. Bock | M | 59 |
The University of California, San Francisco
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 years |
| Michael Kauffman | M | 60 | 3 years | |
| Annette C. North | F | 58 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | 1 years |
| Julian Adams | M | 69 |
Massachusetts Institute of Technology
| 15 years |
| Peter Staple | M | 72 |
BioSeek, Inc.
 BioSeek, Inc. Miscellaneous Commercial ServicesCommercial Services BioSeek, an Asterand company, is improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. Their BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative biological activity profiles for each potential drug. As a result, their technology drives the selection and development of new drug candidates. they leverage their BioMAP® Systems technology in collaborations to enhance the productivity of their pharmaceutical partners' pipelines to identify promising compounds for therapeutic development. Asterand plc acquired BioSeek on February 18, 2010. Asterand is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. BioSeek's BioMAP® platform and primary human cell based assays are highly complementary to the human tissue-based products and services offered by Asterand. Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, Asterand plc is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From their offices in Royston (United Kingdom), San Francisco, California and Detroit, Michigan they have more than 90 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety. | 6 years |
| George Economou | M | 71 |
Massachusetts Institute of Technology
| 5 years |
| Brian Jacobs | M | 63 |
Massachusetts Institute of Technology
| 5 years |
| Steven Shak | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| Paul Hastings | M | 64 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | 2 years |
| Steven Holtzman | M | 70 | 17 years | |
| Dave Grayzel | M | 56 | 8 years | |
| Eric S. Lander | M | 67 | 10 years | |
| Vito Palombella | M | 61 | 12 years | |
| Gregory D. Hawkins | M | - |
Massachusetts Institute of Technology
| 8 years |
| Robert McDowell | M | 66 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA.
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 12 years |
| Elizabeth Marie Robinson | M | - |
Massachusetts Institute of Technology
| 4 years |
| Brian Daniels | M | 65 |
Massachusetts Institute of Technology
| 4 years |
| Daniel Petree | M | 68 |
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | 6 years |
| Ethan E. Jacks | M | 70 |
Massachusetts Institute of Technology
| 5 years |
| Elias Samaras | M | 69 |
Massachusetts Institute of Technology
| 1 years |
| Howard Mayson | M | 71 |
Massachusetts Institute of Technology
| 1 years |
| Thomas C. Tiller | M | 62 |
Massachusetts Institute of Technology
| 4 years |
| Robert S. Rosenschein | M | 70 |
Massachusetts Institute of Technology
| 4 years |
| Peter C. Schechter | M | - |
Massachusetts Institute of Technology
| 4 years |
| Mark Gorenberg | M | 69 |
Massachusetts Institute of Technology
| 4 years |
| Tom Reed | M | - |
Massachusetts Institute of Technology
| 4 years |
| Gary Pajer | M | - |
Massachusetts Institute of Technology
| 4 years |
| Jeffrey L. Shames | M | 68 |
Massachusetts Institute of Technology
| 4 years |
| Vikram Shreekant Kirloskar | M | 65 |
Massachusetts Institute of Technology
| 4 years |
| Mohamed Hesham El-Sherief | M | - |
Massachusetts Institute of Technology
| 3 years |
| Zakaria bin Ahmad | M | 77 |
Massachusetts Institute of Technology
| 3 years |
| Lisa Granick | F | - |
Massachusetts Institute of Technology
| 4 years |
| Chi-Won Yoon | M | 65 |
Massachusetts Institute of Technology
| 4 years |
| Poh Kam Wong | M | 72 |
Massachusetts Institute of Technology
| 3 years |
| Frederick Wilson | M | 62 |
Massachusetts Institute of Technology
| 4 years |
| Bruce Greenwald | M | - |
Massachusetts Institute of Technology
| 3 years |
| Pete Sinclair | M | - |
Massachusetts Institute of Technology
| 4 years |
| Nick Nocerino | M | - |
Massachusetts Institute of Technology
| 6 years |
| David Bour | M | - |
Massachusetts Institute of Technology
| 4 years |
| Alfred Spada | M | 66 |
Massachusetts Institute of Technology
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael C. Venuti
- Personal Network
